Factors associated with latent tuberculosis among asylum seekers in Switzerland: A cross-sectional study in Vaud County

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Sarivalasis, Apostolos ^a   Zellweger, Jean Pierre ^b   Faouzi, Mohamed ^c   Daher, Oscar ^d   Deslarzes, Charlotte ^e   Bodenmann, Patrick ^a  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^b Swiss Lung Association   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d Health Center Sainte Croix Hospital (CSSC)   (Switzerland)

^e Nurse Health Center (CSI)   (Switzerland)

Author keywords

Asylum seeker; Interferon gamma release assay; Latent tuberculosis infection; Predictive score; Risk factors; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGE; ANAMNESIS; ARTICLE; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PILOT STUDY; PREDICTIVE VALUE; PREVALENCE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SPUTUM CULTURE; SPUTUM EXAMINATION; SWITZERLAND; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REFUGEES; SWITZERLAND; YOUNG ADULT;

EID: 84868221826     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-285     Document Type: Article

References (16)

1. Pareek M, Watson JP, Ormerod LP, Kon OM, Woltmann G, White PJ, Abubakar I, Lalvani A. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis 2011, 11(6):435-444.
2. Moran-Mendoza O, Marion SA, Elwood K, Patrick D, FitzGerald JM. Risk factors for developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases. Int J Tuberc Lung Dis 2010, 14(9):1112-1119.
3. Diel R, Wrighton-Smith P, Zellweger JP. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 2007, 30(2):321-332.
4. Dasgupta K, Menzies D. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 2005, 25(6):1107-1116.
5. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2007, 11(1):16-26.
6. Meima A, de Vlas SJ. Pulmonary tuberculosis incidence in migrants 2008, Rotterdam: Erasmus University, dept of public health.
7. Breuss E, Helbling P, Altpeter E, Zellweger JP. Screening and treatment for latent tuberculosis infection among asylum seekers entering Switzerland. Swiss Med Wkly 2002, 132(15-16):197-200.
8. Pai M, Minion J, Sohn H, Zwerling A, Perkins MD. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med 2009, 30(4):701-716. viii.
9. Mulder C, Huisman EM, Toumanian S, Koster BFPJ, Meijer-Veldman W, van Loenhout-Rooyackers JH, Appel M, Arend SMBM, van Leth F. Role of Quantiferon-TB Gold In-Tube in screening new immigrants for tuberculosisinfection. Eur Resp J 2012,
10. Harstad I, Heldal E, Steinshamn SL, Garasen H, Winje BA, Jacobsen GW. Screening and treatment of latent tuberculosis in a cohort of asylum seekers in Norway. Scand J Public Health 2010, 38(3):275-282.
11. National Institute for Health and Clinical Excellence Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control 2011, London, NICE clinical Guideline 117, National Collaborative Center for Clinical Excellence, National Institute for Health and Clinical Excellence.
12. Winje BA, Oftung F, Korsvold GE, Mannsaker T, Jeppesen AS, Harstad I, Heier BT, Heldal E. Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test. BMC Infect Dis 2008, 8:65.
13. Hardy AB, Varma R, Collyns T, Moffitt SJ, Mullarkey C, Watson JP. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. Thorax 2010, 65(2):178-180.
14. Ricks PM, Cain KP, Oeltmann JE, Steve Kammerer J, Moonan PK. Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005-2009. PLoS One 2011, 6(11):e27405.
15. Lienhardt C, Fielding K, Sillah JS, et al. Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol 2005, 34:914-923.
16. Chiang CY, Slama K, Enarson DA. Associations between tobacco and tuberculosis. Int J Tuberc Lung Dis 2007, 11(3):258-262.